J. Koetsveld

发表

Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.

E. Fikrig, M. Embers, H. Sprong, 2020, Clinical Microbiology and Infection.

ATP-Binding Cassette Transporter G1 and High-Density Lipoprotein Promote Endothelial NO Synthesis Through a Decrease in the Interaction of Caveolin-1 and Endothelial NO Synthase

A. Tall, C. Fernández-Hernando, W. Sessa, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Increased Atherosclerosis in Mice With Vascular ATP-Binding Cassette Transporter G1 Deficiency—Brief Report

A. Tall, C. Welch, I. Goldberg, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Carriers of Loss-of-Function Mutations in ABCA1 Display Pancreatic β-Cell Dysfunction

M. Hayden, J. Kastelein, E. Stroes, 2008, Diabetes Care.

Whole genome sequencing of Borrelia miyamotoi isolate Izh-4: reference for a complex bacterial genome

M. Markelov, V. Fingerle, K. Kuleshov, 2019, BMC Genomics.

Prevalence and clinical manifestation of Borrelia miyamotoi in Ixodes ticks and humans in the northern hemisphere: a systematic review and meta-analysis.

H. Sprong, R. Spijker, A. Platonov, 2022, The Lancet. Microbe.

In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1[S]

J. Kastelein, J. Kastelein, S. Turner, 2013, Journal of Lipid Research.

Borrelia miyamotoi Activates Human Dendritic Cells and Elicits T Cell Responses

T. Geijtenbeek, Tanja M. Kaptein, A. Oei, 2019, The Journal of Immunology.

Serological and molecular evidence for spotted fever group Rickettsia and Borrelia burgdorferi sensu lato co-infections in The Netherlands.

H. Sprong, E. Tijsse-Klasen, T. Herremans, 2016, Ticks and tick-borne diseases.

Identification of novel conserved Ixodes vaccine candidates; a promising role for non-secreted salivary gland proteins.

S. Narasimhan, J. Anguita, R. Sima, 2022, Vaccine.

Variable Major Proteins as Targets for Specific Antibodies against Borrelia miyamotoi

T. van der Poll, E. Fikrig, S. Narasimhan, 2016, The Journal of Immunology.

Assessment of Borrelia miyamotoi in febrile patients and ticks in Alsace, an endemic area for Lyme borreliosis in France

H. Sprong, N. Boulanger, Y. Hansmann, 2020, Parasites & Vectors.

Serodiagnosis of Borrelia miyamotoi disease by measuring antibodies against GlpQ and variable major proteins.

R. Dessau, A. Platonov, W. Ang, 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents

C. Visser, A. Oei, J. Hovius, 2017, Antimicrobial Agents and Chemotherapy.

Development and optimization of an in vitro cultivation protocol allows for isolation of Borrelia miyamotoi from patients with hard tick-borne relapsing fever.

A. Platonov, A. Oei, J. Hovius, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties

P. Zipfel, R. Wallich, V. Fingerle, 2017, Scientific Reports.

This information is current as miyamotoi Borrelia Specific Antibodies against Variable Major Proteins as Targets for

E. Fikrig, S. Narasimhan, L. Bockenstedt, 2016 .

Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe

H. Sprong, A. Platonov, J. Hovius, 2018, Emerging infectious diseases.

[Clinical presentation of Ixodes tick-borne borreliosis caused by Borrelia miyamotoi in the context of an immune response to the pathogen].

G. Shipulin, A. Platonov, V. Maleev, 2017, Terapevticheskii arkhiv.

Cathepsin L, target in cancer treatment?

A. H. van der Spek, C. Van Noorden, T. Barwari, 2010, Life sciences.

In Vitro Antimicrobial Susceptibility of Clinical Isolates of Borrelia miyamotoi

A. Platonov, A. Oei, J. Hovius, 2018, Antimicrobial Agents and Chemotherapy.

Cholesteryl ester transfer protein inhibition: a dysfunctional endothelium.

A. Tall, M. Westerterp, J. Koetsveld, 2010, Journal of cardiovascular pharmacology.

Ixodes scapularis dystroglycan-like protein promotes Borrelia burgdorferi migration from the gut

E. Fikrig, S. Narasimhan, A. Oei, 2015, Journal of Molecular Medicine.

BACTERICIDAL EFFECT OF HUMAN SERUM ON BORRELIA MIYAMOTOI, CAUSATIVE AGENT OF IXODES TICK-BORNE BORRELIOSIS (ITBB-BM)

A. Platonov, A. Dolgova, O. Stukolova, 2018 .

Whole-Genome Sequencing of Six Borrelia miyamotoi Clinical Strains Isolated in Russia

M. Markelov, K. Kuleshov, G. Shipulin, 2018, Genome Announcements.

Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties

P. Zipfel, R. Wallich, V. Fingerle, 2017, Scientific Reports.

Abstract 17881: In vivo Tissue Cholesterol Efflux is Impaired in Carriers of Mutations in APOA1 and ABCA1

J. Kastelein, E. Stroes, S. Turner, 2010 .

Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe

H. Sprong, A. Platonov, J. Hovius, 2018, Emerging infectious diseases.

In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents

C. Visser, A. Oei, J. Hovius, 2017, Antimicrobial Agents and Chemotherapy.

Abstract 1924: Carriers of Loss-of-Function Mutations in ABCA1 Display Pancreatic Beta Cell Dysfunction

M. Hayden, J. Kastelein, E. Stroes, 2008 .